Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1

FEBS Letters

Volumn 579, Issue 21, 2005, Pages 4763-4768

  Tee, Andrew R ^a   Blenis, John ^b   Proud, Christopher G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

4E BP1; mTOR; Rheb; RhebL1; S6K1; TSC2

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; RHEB LIKE 1 PROTEIN; RHEB PROTEIN; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MUTATION; NUTRIENT; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CELL LINE; HUMANS; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; NEUROPEPTIDES; PROTEIN KINASES; RAS PROTEINS; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA;

EID: 24044442298     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.07.054     Document Type: Article

References (13)

1. G.W. Reuther, and C.J. Der The Ras branch of small GTPases: Ras family members don't fall far from the tree Curr. Opin. Cell Biol. 12 2000 157 165
2. A.R. Tee, and J. Blenis mTOR, translational control and human disease Semin. Cell Dev. Biol. 16 2005 29 37
3. A.R. Tee, B.D. Manning, P.P. Roux, L.C. Cantley, and J. Blenis Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb Curr. Biol. 13 2003 1259 1268
4. A. Wittinghofer Signal transduction via Ras Biol. Chem. 379 1998 933 937
5. S.A. Moodie, M. Paris, E. Villafranca, P. Kirshmeier, B.M. Willumsen, and A. Wolfman Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets Oncogene 11 1995 447 454
6. J. Fujita-Yoshigaki, M. Shirouzu, Y. Ito, S. Hattori, S. Furuyama, S. Nishimura, and S. Yokoyama A constitutive effector region on the C-terminal side of switch I of the Ras protein J. Biol. Chem. 270 1995 4661 4667
7. A.R. Tee, D.C. Fingar, B.D. Manning, D.J. Kwiatkowski, L.C. Cantley, and J. Blenis Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling Proc. Natl. Acad. Sci. USA 99 2002 13571 13576
8. S.S. Schalm, and J. Blenis Identification of a conserved motif required for mTOR signaling Curr. Biol. 12 2002 632 639
9. D.C. Fingar, S. Salama, C. Tsou, E. Harlow, and J. Blenis Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E Genes Dev. 16 2002 1472 1487
10. J.J. Fiordalisi, S.P. Holly, R.L. Johnson II, L.V. Parise, and A.D. Cox A distinct class of dominant negative Ras mutants: cytosolic GTP-bound Ras effector domain mutants that inhibit Ras signaling and transformation and enhance cell adhesion J. Biol. Chem. 277 2002 10813 10823
11. E.M. Smith, S.G. Finn, A.R. Tee, G.J. Browne, and C.G. Proud The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses J. Biol. Chem. 280 2005 18717 18727
12. X. Long, Y. Lin, S. Ortiz-Vega, K. Yonezawa, and J. Avruch Rheb binds and regulates the mTOR kinase Curr. Biol. 15 2005 702 713
13. X. Long, S. Ortiz-Vega, Y. Lin, and J. Avruch Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency J. Biol. Chem. 280 2005 23433 23436